Related references
Note: Only part of the references are listed.Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease (Sep, 10.1038/s41409-020-01049-0, 2020)
Natasha Kekre et al.
BONE MARROW TRANSPLANTATION (2021)
Immunomodulatory Effects of Histone Deacetylation Inhibitors in Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation
Xiaoxiao Xu et al.
FRONTIERS IN IMMUNOLOGY (2021)
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings
Margaret L. MacMillan et al.
BLOOD ADVANCES (2021)
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
Jonathan U. Peled et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans
Johana Norona et al.
BLOOD (2020)
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
Kate A. Markey et al.
BLOOD (2020)
Cytokines and costimulation in acute graft-versus-host disease
Geoffrey R. Hill et al.
BLOOD (2020)
Intestinal goblet cells protect against GVHD after allogeneic stem cell transplantation via Lypd8
Takahide Ara et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
T Cell Costimulation Blockade with CTLA4-Ig (Abatacept) for Acute Gvhd Prevention in HLA Matched and Mismatched Unrelated Donor Transplantation: Results of the First Phase 2 Trial
Ben K. Watkins et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
Javier Bolanos-Meade et al.
LANCET HAEMATOLOGY (2019)
MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota
Motoko Koyama et al.
IMMUNITY (2019)
Lactose drives Enterococcus expansion to promote graft-versus-host disease
C. K. Stein-Thoeringer et al.
SCIENCE (2019)
Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers A Systematic Review and Meta-analysis
Nico Gagelmann et al.
JAMA ONCOLOGY (2019)
The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease
Motoko Koyama et al.
BLOOD (2019)
IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling
Andrew N. Wilkinson et al.
BLOOD (2019)
T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage
S. Takashima et al.
SCIENCE IMMUNOLOGY (2019)
Ocular instillation of vitamin A-coupled liposomes containing HSP47 siRNA ameliorates dry eye syndrome in chronic GVHD
Hiroyuki Ohigashi et al.
BLOOD ADVANCES (2019)
Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Yi-Bin Chen et al.
BLOOD ADVANCES (2019)
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation
Mi Kwon et al.
BLOOD ADVANCES (2019)
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future
Tessa M. Andermann et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
John M. Magenau et al.
BLOOD (2018)
Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease
Tomohiro Yamakawa et al.
BLOOD (2018)
Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
Shuichiro Takahashi et al.
BLOOD (2018)
CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates
Benjamin K. Watkins et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Microbial metabolite sensor GPR43 controls severity of experimental GVHD
Hideaki Fujiwara et al.
NATURE COMMUNICATIONS (2018)
Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts
Jonathan E. Wosen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
Joshua N. Kellner et al.
Oncotarget (2018)
Essential ole of IFN-γ in T cell-associated intestinal inflammation
Yoshihiro Eriguchi et al.
JCI INSIGHT (2018)
A critical role for donor-derived IL-22 in cutaneous chronic GVHD
Kate H. Gartlan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Chronic graft-versus-host disease: biological insights from preclinical and clinical studies
Kelli P. A. MacDonald et al.
BLOOD (2017)
Cytokine mediators of chronic graft-versus-host disease
Kelli P. A. MacDonald et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease
Eiko Hayase et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease
Jerome Legoff et al.
NATURE MEDICINE (2017)
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versushost disease
Ruishu Deng et al.
NATURE COMMUNICATIONS (2017)
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David Miklos et al.
BLOOD (2017)
Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT
Sung Won Choi et al.
BLOOD (2017)
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production
Jing Du et al.
BLOOD (2017)
Tissue tolerance: a distinct concept to control acute GVHD severity
Shin-Rong Wu et al.
BLOOD (2017)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
Claudio G. Brunstein et al.
BLOOD (2016)
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
Ryan Flynn et al.
BLOOD (2016)
Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner
Cameron McDonald-Hyman et al.
BLOOD (2016)
Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality
Shigeo Fuji et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
Stephanie J. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease
Ryan Flynn et al.
BLOOD (2015)
Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects
Kate H. Gartlan et al.
BLOOD (2015)
α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice
Hidetaka Uryu et al.
BLOOD (2015)
Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts
Marie Bleakley et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Donor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease
Motoko Koyama et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R. Zeiser et al.
LEUKEMIA (2015)
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
Caroline A. Lindemans et al.
NATURE (2015)
Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention
Scott N. Furlan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation
H. Nakasone et al.
BONE MARROW TRANSPLANTATION (2015)
Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease
Ernst Holler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
JAK inhibitors: a home run for GVHD patients?
Takanori Teshima
BLOOD (2014)
α-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics
A. Mario Marcondes et al.
BLOOD (2014)
The biology of graft-versus-host disease: experimental systems instructing clinical practice
Kate A. Markey et al.
BLOOD (2014)
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
Ying Taur et al.
BLOOD (2014)
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
Massimo F. Martelli et al.
BLOOD (2014)
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans
Ryan Flynn et al.
BLOOD (2014)
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
Silvia Spoerl et al.
BLOOD (2014)
CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease
Kylie A. Alexander et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage
Lukas Schwab et al.
NATURE MEDICINE (2014)
Antigen and Lymphopenia-Driven Donor T Cells Are Differentially Diminished by Post-Transplantation Administration of Cyclophosphamide after Hematopoietic Cell Transplantation
Duncan Ross et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial
Divya T. Koura et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality
John E. Levine et al.
BLOOD (2013)
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
Christopher G. Kanakry et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
Ken-ichi Matsuoka et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Mouse Models in Bone Marrow Transplantation and Adoptive Cellular Therapy
Caroline Arber et al.
SEMINARS IN HEMATOLOGY (2013)
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Madan Jagasia et al.
BLOOD (2012)
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
Mathangi Srinivasan et al.
BLOOD (2012)
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins
Yoshihiro Eriguchi et al.
BLOOD (2012)
Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease
Alan M. Hanash et al.
IMMUNITY (2012)
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
Robert R. Jenq et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Profound Depletion of Host Conventional Dendritic Cells, Plasmacytoid Dendritic Cells, and B Cells Does Not Prevent Graft-versus-Host Disease Induction
Hongmei Li et al.
JOURNAL OF IMMUNOLOGY (2012)
Donor B Cells in Transplants Augment Clonal Expansion and Survival of Pathogenic CD4+ T Cells That Mediate Autoimmune-like Chronic Graft-versus-Host Disease
James S. Young et al.
JOURNAL OF IMMUNOLOGY (2012)
Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels
F. Leonhardt et al.
LEUKEMIA (2012)
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease
Motoko Koyama et al.
NATURE MEDICINE (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation
Isao Tawara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation
Xiaojian Wang et al.
BLOOD (2011)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells
Shuichiro Takashima et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease
Nathan Cantoni et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma
Geoffrey R. Hill et al.
BLOOD (2010)
The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status
Walter J. F. M. van der Velden et al.
CLINICAL IMMUNOLOGY (2010)
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stern cell transplantation
Ken-ichi Matsuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma
Kazuhito Yamamoto et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation
Kate A. Markey et al.
BLOOD (2009)
In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
Michael J. Carlson et al.
BLOOD (2009)
Mouse models of bone marrow transplantation
Pavan Reddy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells
Britt E. Anderson et al.
BLOOD (2008)
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice
Pavan Reddy et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
A new murine model for bronchiolitis obliterans post-bone marrow transplant
Angela Panoskaltsis-Mortari et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations
CY Zhang et al.
BLOOD (2006)
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
E Zorn et al.
BLOOD (2005)
Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ
BE Anderson et al.
BLOOD (2005)
Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease
JH Antin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Donor APCs are required for maximal GVHD but not for GVL
CC Matte et al.
NATURE MEDICINE (2004)
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial
SJ Lee et al.
BLOOD (2004)
Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease
UA Duffner et al.
JOURNAL OF IMMUNOLOGY (2004)
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
M Mielcarek et al.
BLOOD (2003)
Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction
M Murai et al.
NATURE IMMUNOLOGY (2003)
CW/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects
U Jung et al.
BLOOD (2003)
CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease
JL Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
T Teshima et al.
NATURE MEDICINE (2002)
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
PA Taylor et al.
BLOOD (2002)
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation
JH Antin et al.
BONE MARROW TRANSPLANTATION (2002)
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide
PV O'Donnell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial
E Kansu et al.
BLOOD (2001)
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation
KR Cooke et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
